# Investigational Study of Delayed Release Metformin

> **NCT04854512** · PHASE3 · SUSPENDED · sponsor: **Anji Pharma** · enrollment: 675 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Metformin DR
- **DRUG:** Metformin IR
- **DRUG:** Metformin DR Placebo
- **DRUG:** Metformin IR placebo

## Key facts

- **NCT ID:** NCT04854512
- **Lead sponsor:** Anji Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2021-05-18
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-06-30
- **Target enrollment:** 675 (ESTIMATED)
- **Why stopped:** Strategic company decision - not related to a safety concern
- **Last updated:** 2023-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04854512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04854512, "Investigational Study of Delayed Release Metformin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04854512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*